Generic Name: cladribine
Applies to cladribine: intravenous solution
Along with its needed effects, cladribine (the active ingredient contained in Leustatin) may cause some unwanted effects. Some side effects will have signs or symptoms that you can see or feel. Your doctor may watch for others by doing certain tests.
Also, because of the way cancer medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer. Discuss these possible effects with your doctor.
You should check with your doctor immediately if any of these side effects occur when taking cladribine:
If any of the following side effects occur while taking cladribine, check with your doctor or nurse as soon as possible:
This medicine may also cause the following side effects that your doctor will watch out for:
Some of the side effects that can occur with cladribine may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to cladribine: intravenous solution
Very common (10% or more): Neutropenia, thrombocytopenia, anemia, purpuraCommon (1% to 10%): Febrile neutropeniaUncommon (0.1% to 1%): Bone marrow suppression with prolonged pancytopenia, aplastic anemia, hypereosinophilia, myelodysplastic syndromePostmarketing reports: Hemolytic anemia, anemia, febrile neutropenia[Ref]
Common (1% to 10%): Renal failure (including renal failure acute, renal impairment)
Very common (10% or more): Nausea (28%), anorexia (17%), vomiting (13%), diarrhea (10%)Common (1% to 10%): Constipation, abdominal pain, flatulenceUncommon (0.1% to 1%): Mucositis[Ref]
Very common (10% or more): Rash (28%), diaphoresis, pruritusCommon (1% to 10%): Hyperhidrosis, petechiae, ecchymosis, urticaria, petechiaeUncommon (0.1% to 1%): Stevens-Johnson syndrome, toxic skin eruption, toxic epidermal necrolysisRare (less than 0.1%): AlopeciaVery rare (less than 0.01%): Epidermal necrolysisPostmarketing reports: Hypereosinophilia[Ref]
Very common (10% or more): HeadacheCommon (1% to 10%): Dizziness, somnolenceUncommon (0.1% to 1%): Depressed level of consciousness, neurological toxicity (including peripheral sensory neuropathy, motor neuropathy (paralysis), polyneuropathy, paraparesis)[Ref]
Very common (10% or more): Administration site reaction[Ref]
Uncommon (0.1% to 1%): Tumor lysis syndrome, metabolic acidosis[Ref]
Common (1% to 10%): Edema, tachycardia, myocardial ischemia, peripheral edemaRare (less than 0.1%): Heart failure, arrhythmia, heart murmur, hypotension, thrombosis[Ref]
Common (1% to 10%): Arthralgia, myalgia, painUncommon (0.1% to 1%): Muscular weakness, paraparesis[Ref]
Very common (10% or more): CoughCommon (1% to 10%): Pulmonary interstitial infiltrates (including lung infiltration, interstitial lung disease, pneumonitis and pulmonary fibrosis), abnormal breath sounds, abnormal chest sounds, dyspnea, rales[Ref]
Common (1% to 10%): Hypersensitivity[Ref]
Uncommon (0.1% to 1%): Increases in bilirubin, increases in transaminases, jaundice[Ref]
Very common (10% or more): Infection (unspecified) (up to 28%)Common (1% to 10%): Bacteremia, cellulitis, localized infection, pneumonia, septic shock, serious infection, opportunistic infection[Ref]
Postmarketing reports: Conjunctivitis[Ref]
Very common (10% or more): Fatigue, pyrexiaCommon (1% to 10%): Asthenia, chills, malaise, localized edema, chills, weight loss[Ref]
Postmarketing reports: Secondary malignancies[Ref]
Common (1% to 10%): Confusion, anxiety, insomnia[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):
3. "Product Information. Leustatin (cladribine)." Ortho Biotech Inc, Raritan, NJ. 
Not all side effects for Leustatin may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Black, tarry stools
blood in urine 
cough or hoarseness, accompanied by fever or chills 
fever
lower back or side pain, accompanied by fever or chills
painful or difficult urination, accompanied by fever or chills
 pinpoint red spots on skin
unusual bleeding or bruising 


Skin rash


Pain or redness at place of injection
 shortness of breath
stomach pain
 swelling of feet or lower legs
unusually fast heartbeat 


Anemia
low white cell counts in blood 


Headache
loss of appetite
nausea
unusual tiredness
vomiting


Constipation
diarrhea
dizziness
general feeling of discomfort or illness
itching
muscle or joint pain
sweating
 trouble in sleeping
weakness

